BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 1332175)

  • 21. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
    Kumamoto T; Ueyama H; Tsumura H; Toyoshima I; Tsuda T
    Acta Neuropathol; 2004 Jan; 107(1):59-65. PubMed ID: 14513262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inclusion body myopathy associated with motor neuron syndrome: three case reports.
    Cafforio G; Pistolesi S; D'Avino C; Galluzzi F; Patricelli A; Solito B; Fontanini G; Siciliano G
    Clin Neuropathol; 2005; 24(1):36-41. PubMed ID: 15696783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autosomal dominant distal myopathy with rimmed vacuoles and cytoplasmic inclusions: report of a family].
    Uesaka Y; Nakamichi K; Kojima S; Ida M; Takagi A
    Rinsho Shinkeigaku; 1997 Jan; 37(1):1-6. PubMed ID: 9146065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.
    Figarella-Branger D; Pellissier JF; Bianco N; Devictor B; Toga M
    Acta Neuropathol; 1990; 79(5):528-36. PubMed ID: 2158202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytoplasmic inclusion bodies: a study in several diseases and a review of the literature].
    Scola RH; Werneck LC; Franco CR
    Arq Neuropsiquiatr; 1996 Jun; 54(2):245-59. PubMed ID: 8984983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inclusion body myositis associated with sacroidosis: a report of 3 cases].
    Bouillot S; Coquet M; Ferrer X; Lagueny A; Leroy JP; Vital C
    Ann Pathol; 2001 Aug; 21(4):334-6. PubMed ID: 11685131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitin and beta-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study.
    Leclerc A; Tomé FM; Fardeau M
    Neuromuscul Disord; 1993 Jul; 3(4):283-91. PubMed ID: 8268725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells.
    Dalakas MC; Illa I
    Ann Neurol; 1995 Jun; 37(6):806-10. PubMed ID: 7778855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hereditary inclusion-body myopathy].
    Kucharz EJ
    Przegl Lek; 1999; 56(11):735-8. PubMed ID: 10800587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis.
    Askanas V; Engel WK; Alvarez RB
    Am J Pathol; 1992 Jul; 141(1):31-6. PubMed ID: 1321564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inclusion-body myositis: a familial report of 3 cases].
    Miró i Andreu O; Fernández-Solá J; Pedrol Clotet E; Coll-Vinent B; Casademont Pou J; Grau Junyent JM; Urbano-Márquez A
    Rev Clin Esp; 1994 Nov; 194(11):974-7. PubMed ID: 7846355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inclusion body myositis (IBM).
    Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
    Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vacuolar changes in neuromuscular disorders: a morphometric study.
    Lee CC; Huang CC; Chen SS
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Dec; 56(6):386-92. PubMed ID: 8851479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of inclusion body myositis.
    Cherin P
    Curr Opin Rheumatol; 1999 Nov; 11(6):456-61. PubMed ID: 10551668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the intermediate filament protein synemin in myofibrillar myopathies and other muscle diseases.
    Olivé M; Goldfarb L; Dagvadorj A; Sambuughin N; Paulin D; Li Z; Goudeau B; Vicart P; Ferrer I
    Acta Neuropathol; 2003 Jul; 106(1):1-7. PubMed ID: 12669240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.
    Greenberg SA; Pinkus JL; Amato AA
    Muscle Nerve; 2006 Oct; 34(4):406-16. PubMed ID: 16823856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion body myositis: a chronic persistent mumps myositis?
    Chou SM
    Hum Pathol; 1986 Aug; 17(8):765-77. PubMed ID: 3015764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis.
    Prayson RA; Cohen ML
    Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.